← FDA Drug Approvals (Drugs@FDA)

SPIRONOLACTONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS ELIZABETH · Approved 1999-07-29

Drug application

FDA Application #

ANDA040353

Application type

Abbreviated New Drug Application (Generic)

Brand name

SPIRONOLACTONE

Generic name

Spironolactone

Active ingredients

SPIRONOLACTONE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ACTAVIS ELIZABETH

First approval

1999-07-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown